BACE1: Expression, Regulation, and Therapeutic Potential of the Major Alzheimer's Disease Beta-Secretase

E-ISSN： 1875-6662|9|1|3-14

ISSN： 1573-4080

Source： Current Enzyme Inhibition, Vol.9, Iss.1, 2013-05, pp. : 3-14

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Translational regulation of BACE‐1 expression in neuronal and non‐neuronal cells

By De Pietri Tonelli Davide Mihailovich Marija Di Cesare Alessandra Codazzi Franca Grohovaz Fabio Zacchetti Daniele

Nucleic Acids Research, Vol. 32, Iss. 5, 2004-03 ,pp. : 1808-1817

Oxford University Press

Access to resources Recommend Favorite

A new BACE is for therapy of Alzheimer's disease

By Kahana J.

Trends in Cell Biology, Vol. 11, Iss. 5, 2001-05 ,pp. : 192-192

Elsevier

Access to resources Recommend Favorite

Computer-Aided Drug Design Applied to Beta and Gamma Secretase Inhibitors-Perspectives for New Alzheimer Disease Therapy

Current Enzyme Inhibition, Vol. 2, Iss. 4, 2006-11 ,pp. : 311-328

Bentham Science Publishers

Access to resources Recommend Favorite

Protein expression of BACE1, BACE2 and APP in Down syndrome brains

By Cheon M. S. Dierssen M. Kim S. H. Lubec G.

Amino Acids, Vol. 35, Iss. 2, 2008-08 ,pp. : 339-343

Springer Publishing Company

Access to resources Recommend Favorite

β-Arrestins as Potential Therapeutic Targets for Alzheimer’s Disease

By Jiang Teng Yu Jin-Tai Tan Meng-Shan Zhu Xi-Chen Tan Lan

Molecular Neurobiology, Vol. 48, Iss. 3, 2013-12 ,pp. : 812-818

Humana Press, Inc

Access to resources Recommend Favorite